KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 97 filers reported holding KURA ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $487,983 | +3.8% | 23,700 | +64.7% | 0.03% | +183.3% |
| Q4 2020 | $470,000 | +351.9% | 14,391 | +324.8% | 0.01% | +140.0% |
| Q3 2020 | $104,000 | +642.9% | 3,388 | +276.4% | 0.01% | +400.0% |
| Q4 2017 | $14,000 | -48.1% | 900 | -50.0% | 0.00% | -50.0% |
| Q3 2017 | $27,000 | +800.0% | 1,800 | +350.0% | 0.00% | – |
| Q4 2015 | $3,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |